Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
12.56
+1.15 (10.08%)
At close: May 12, 2025, 4:00 PM
12.80
+0.24 (1.91%)
After-hours: May 12, 2025, 5:17 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $1.43 billion as of May 12, 2025. Its market cap has decreased by -33.68% in one year.
Market Cap
1.43B
Enterprise Value
773.49M
1-Year Change
-33.68%
Ranking
Category
Stock Price
$12.56
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $1.43B, an increase of 80.51%. That is a compound annual growth rate of 13.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 1.30B | -45.91% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.83B |
| Johnson & Johnson | 371.18B |
| UnitedHealth Group | 344.78B |
| AbbVie | 333.28B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.94B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |